Still a role for second-line chemoimmunotherapy in chronic lymphocytic leukemia? by Jennifer R Brown

Get full text

Response to Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients” by Jennifer R. Brown

Get full text

PI3K inhibitors in chronic lymphocytic leukemia: where do we go from here? by Sigrid S. Skånland, Jennifer R. Brown

Get full text

Targeting Bruton’s Tyrosine Kinase in CLL by Inhye E. Ahn, Jennifer R. Brown

Get full text

Assaying and Classifying T Cell Function by Cell Morphology by Xin Wang, Stacey M. Fernandes, Jennifer R. Brown, Lance C. Kam

Get full text

Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia – Passé Yet? by Alexey V. Danilov, John M. Pagel, Jennifer R. Brown, Brian T. Hill

Get full text

Editorial: New Insights on Bruton’s Tyrosine Kinase Inhibitors by C. I. Edvard Smith, Jennifer R. Brown, Rula Zain, Rula Zain

Get full text

Editorial: Targeting Bruton Tyrosine Kinase by Cornelia Brunner, Annika C. Betzler, Jennifer R. Brown, Amy H. Andreotti, Emanuela Grassilli

Get full text

4321 Personalization of T cell production for cellular immunotherapy by Dennis Jinglun Yuan, Shuai Shao, Joanne H Lee, Stacey M Fernandes, Jennifer R Brown, Lance C Kam

Get full text

The phase III DUO trial of PI3K inhibitor duvelisib versus ofatumumab in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final analysis including overa... by Alexey V. Danilov, Ian W. Flinn, Matthew S. Davids, Beth Gregory, Ohad Bentur, David Sidransky, Jennifer R. Brown

Get full text

Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice by Susan M. O’Brien, Jennifer R. Brown, John C. Byrd, Richard R. Furman, Paolo Ghia, Jeff P. Sharman, William G. Wierda

Get full text

Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target by Carlos Cuesta-Mateos, Carlos Cuesta-Mateos, Carlos Cuesta-Mateos, Jennifer R. Brown, Fernando Terrón, Fernando Terrón, Cecilia Muñoz-Calleja, Cecilia Muñoz-Calleja

Get full text

P640: ZANUBRUTINIB VS IBRUTINIB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LYMPHOMA (R/R CLL/SLL): IMPACT ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) by Barbara Eichhorst, Nicole Lamanna, Susan O’brien, Constantine Tam, Lugui Qiu, Keri Yang, Ken Wu, Tommi Salmi, Gisoo Barnes, Jennifer R. Brown

Get full text

Recrystallization inhibition in ice due to ice binding protein activity detected by nuclear magnetic resonance by Jennifer R. Brown, Joseph D. Seymour, Timothy I. Brox, Mark L. Skidmore, Chen Wang, Brent C. Christner, Bing-Hao Luo, Sarah L. Codd

Get full text

MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells. by Shuqiang Li, Howell F Moffett, Jun Lu, Lillian Werner, Hao Zhang, Jerome Ritz, Donna Neuberg, Kai W Wucherpfennig, Jennifer R Brown, Carl D Novina

Get full text

How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic by Davide Rossi, Mazyar Shadman, Adalgisa Condoluci, Jennifer R. Brown, John C. Byrd, Gianluca Gaidano, Michael Hallek, Peter Hillmen, Anthony Mato, Emili Montserrat, Paolo Ghia

Get full text

P644: IBRUTINIB DOSE MODIFICATIONS FOR MANAGEMENT OF CARDIAC ADVERSE EVENTS IN PATIENTS WITH B-CELL MALIGNANCIES: POOLED ANALYSIS OF 10 CLINICAL TRIALS by Deborah Stephens, Jennifer R. Brown, Shuo MA, Michael Wang, Carol Moreno, Tadeusz Robak, Don Stevens, Shane Lee, Chadi Saifan, Emily Hsu, Sima Patel, Jan Burger

Get full text

Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies by Katrine Melvold, Mariaserena Giliberto, Linda Karlsen, Pilar Ayuda‐Durán, Robert Hanes, Toril Holien, Jorrit Enserink, Jennifer R. Brown, Geir E. Tjønnfjord, Kjetil Taskén, Sigrid S. Skånland

Get full text

Investigating the influence of germline <i>ATM</i> variants in chronic lymphocytic leukemia on cancer vulnerability by Roberta S. Azevedo, Francesca Morelli, Kiyomi Mashima, Rayan Fardoun, Svitlana Tyekucheva, Stacey Fernandes, Samantha Shupe, Marissa Terra, Anisha Patel, Matthew S. Davids, Joseph Yu, Jennifer R. Brown

Get full text

Long‐term results of a phase 1/1b study of ibrutinib plus umbralisib for relapsed/refractory chronic lymphocytic leukemia by Christine E. Ryan, Yue Ren, Svitlana Tyekucheva, Jon E. Arnason, Adam M. Boruchov, Caron A. Jacobson, David C. Fisher, Hari Miskin, Peter Sportelli, Jennifer R. Brown, Matthew S. Davids

Get full text